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INTRODUCTION
In primary Sjogren’s syndrome (pSS), there is a well-docu-
mented association of lymphoid malignancies during the
progress of the disease (1). Low-grade non-Hodgkin’s lym-
phomas of B cell origin are the dominant type observed in
association with pSS (2). Reactive plasmacytosis is an extreme-
ly rare condition in association with pSS with only one pre-
vious case report (3). This report describes a patient with pSS
who presented with hypergammaglobulinemia, and exten-
sive bone marrow (BM) and lymph node (LN) plasmacyto-
sis, which mimicked lymphoproliferative malignancy. Also,
in this patient, abnormal differentiation of memory B cells
to plasma cells was observed in the active phase of the dis-
ease, suggesting that abnormal B cell differentiation may
play a role in the pathogenesis of this condition.
CASE REPORT
A 72-yr-old Korean woman presented in February 2003
with recent enlargement of inguinal LNs in association with
fatigue and weight loss of 2 kg in 3 months. She had a pre-
vious history of microscopic hematuria 20 yr ago, and hyper-
thyroidism 15 yr ago. In February 2001, an iron deficiency
anemia refractory to iron supplementation and polyclonal
gammopathy was found during the preoperative workup for
a cataract operation. In October 2001, she was referred to the
rheumatology outpatient clinic for evaluation of autoantibody
positivity, and a diagnosis of pSS was made based on ocular
and oral sicca symptoms for 30 yr, positive Schirmer test, sali-
vary gland involvement on salivary scintigraphy, and FANA
(1:160+, speckled pattern), and rheumatoid factor (26.7 IU/
mL) positivity. Anti-SSA/SSB were negative. Salivary gland
biopsy was not performed.
Physical examination revealed cachexic woman with pale
conjunctiva and multiple inguinal LN enlargement. Labo-
ratory investigations showed a hemoglobin of 7.9 g/dL, white
cell count of 6,800/ L, platelet of 399,000/ L, and MCV of
73.3 fL. ESR was 56 mm/hr and C-reactive protein was 13.0
mg/dL. She had a total protein of 10 g/dL with 7.1 g/dL of
globulin.  2-microglobulin was elevated to 3,490 ng/dL.
Serum electrophoresis demonstrated a polyclonal pattern with
increased amount of IgG (4,610 mg/dL) and IgA (681 mg/dL).
In the BM aspirate, plasma cells were 18.2% of the nucleated
cells. BM biopsy revealed normocellular marrow with mul-
tifocal increase of plasma cells that were normal in morphology
and maturation (Fig. 1A). LN biopsy revealed extensive infil-
tration of plasma cells (Fig. 1B). The LN plasma cells were also
normal in morphology and maturation, and immunostaining
stained equally for both kappa and lambda light chains. Ex-
pression of CD27 on CD19+ peripheral blood B cells enables
the grouping of B cells into 3 populations; CD27- naive B
cells, CD27+ memory B cells, and CD27high plasma cells (4).
Immunofluorescence staining of the peripheral B cells revealed
marked increase of CD19+/CD27high plasma cells and signif-
icant reduction of CD19+/CD27+ memory B cells (Fig. 2A). 
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A Case of Reactive Plasmacytosis Mimicking Multiple Myeloma in 
A Patient with Primary Sjogren’ s Syndrome
Primary Sjogren’s syndrome (pSS) is a chronic autoimmune disease with well-
documented association of lymphoid malignancies during the progress of the dis-
ease. Although several types of malignancy and pseudomalignancy have been
reported in pSS, low-grade non-Hodgkin’s lymphomas are the most frequently
observed. Reactive plasmacytosis mimicking myeloma is a very rare condition in
association with pSS. We describe a 72-yr-old woman with pSS who presented with
hypergammaglobulinemia, and extensive bone marrow and lymph node plasma-
cytosis, which mimicked multiple myeloma. In this patient, there was an abnormal
differentiation of memory B cells to plasma cells in the peripheral blood suggesting
underlying pathogenetic mechanism for this condition. 
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pSS was made. Immunosuppressive therapy with high-dose
glucocorticoid and cyclophosphamide 500 mg IV pulse fort-
nightly was initiated with concerns for malignant transfor-
mation. After completion of 6 cycles of cyclophosphamide
pulse therapy, constitutional symptoms improved and lym-
phadenopathy regressed. Her hemoglobin level improved to
10.9 g/dL and MCV was 84.8 fL. Total protein and globulin
decreased to 8.2 g/dL and 4.9 g/dL, respectively. IgG, IgA,
-2 microglobulin also decreased in significant amount with
IgG 2,350 mg/dL, IgA of 573 mg/dL, and  2 microglobulin
2,630 ng/mL. Upon follow up immunofluorescence staining
of the peripheral B cells, reduction of memory B cells with
abnormal plasmacytosis was no longer observed (Fig. 2B).
The patient is doing clinically well on methylprednisolone
4 mg/day and azathioprine 100 mg/day without any evidence
of lymph node enlargement and malignant transformation
up to present.
DISCUSSION
Our patient manifested with severe anemia, enlarged LNs,
and high serum  2-microglobulin in the course of pSS that
warranted search for malignancy. Although clinical features
mimicked multiple myeloma, the biopsies of LN and BM
revealed benign, polyclonal plasma cell infiltration, compati-
ble with reactive plasmacytosis. Although there are reports
of plasmacytosis at unusual sites such as skin and lung (5, 6),
plasma cell infiltration in the BM in association with pSS is
extremely rare (3). 
This case is unique in that plasma cell infiltration was not
only found in the BM, but also in the LN with abnormal ex-
pansion of plasma cells in the peripheral blood. Recent stud-
ies involving pSS patients have shown that reduction in the
circulating memory B cell compartment is associated with
an increase in serum IgG levels suggesting plasmacytosis
and overactive differentiation of memory B cells to plasma
cells (7, 8). Such abnormal immune reaction has been sug-
gested to play an important role in lymphomagenesis in pSS
(9). We also observed in this case, an abnormal differentia-
tion of memory B cells to plasma cells in the peripheral blood,
which was corrected with immunosuppressive therapy. The
factors that might be responsible for directing a patient with
pSS to develop lymphoproliferative malignancy are still obs-
Fig. 1. Bone marrow biopsy (A) and lymph node biopsy (B) specimens. BM biopsy revealed normocellular marrow with multifocal increase
of plasma cells. Lymph node biopsy shows profound germinal center reaction with infiltration of plasma cells (H&E stain, ×400).
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Fig. 2. Immunofluorescence staining of CD27 on CD19
+ peripheral
blood B cells at baseline (A) and 3 months after treatment (B). At
baseline, there was marked increase of CD19
+/CD27
high plasma
cells and significant reduction of CD19
+/CD27
+ memory B cells.
After treatment, reduction of mermory B cells with abnormal plas-
macytosis was no longer observed. P, plasma cell; M, memory B
cell; N, naive B cell.
A B
C
D
2
7
CD19
10
4
10
3
10
2
10
1
10
0
10
0          10
1           10
2          10
3        10
4
P 24.8%
M 16.1%
N 59.0%
10
4
10
3
10
2
10
1
10
0
10
0          10
1           10
2          10
3       10
4
P3 . 6 %
M 45.3%
N 51.1%508 J. Lee, J.-E. Chang, Y.-J. Cho, et al.
cure. Also therapeutic intervention that can possibly modu-
late lymphomagenesis is unknown. However, accumulation
of cases like ours might enable us to answer these questions. 
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